Trial · NCT07642739
Nature as Medicine for the Healing Brain: Utilization of a Nature-based Exposure Intervention for Decreasing Concussion Recovery Timeline and Symptom Load
NCT07642739, Not applicable, Not yet recruiting, Penn State University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Nature as Medicine for the Healing Brain: Utilization of a Nature-based Exposure Intervention for Decreasing Concussion Recovery Timeline and Symptom Load. Trials, record NCT07642739. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07642739
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Nature as Medicine for the Healing Brain: Utilization of a Nature-based Exposure Intervention for Decreasing Concussion Recovery Timeline and Symptom Load
- NCT number
- NCT07642739
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 24 participants, estimated
- Lead sponsor
- Penn State University
- Conditions
- Concussion (Diagnosis)
- Interventions
- Nature-based Guided Awareness Group, Standard Guided Awareness Group
- First posted
- 2026-06-11
- Last updated
- 2026-06-11
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Concussion Symptoms Scales | Daily, for the duration of the 28 day study | All participants will complete daily Post-Concussion Symptom Scale surveys, offering self-report quantifiable measures of concussion recovery. |
| Secondary | Stroop Task | On day 1 (visit 1) and day 28 (visit 2) of the 28 day study. | Neuropsychological test of processing speed and inhibition |
| Secondary | Oral Digit Symbol Modalities Task | On day 1 (visit 1) and day 28 (visit 2) of the 28 day study. | Neuropsychological measure of attention and memory |
| Secondary | Beck's Depression Inventory | On day 1 (visit 1) and day 28 (visit 2) of the 28 day study. | Depression symptom questionnaire |
| Secondary | Hamilton Anxiety Scale | On day 1 (visit 1) and day 28 (visit 2) of the 28 day study. | Anxiety symptom questionnaire |
| Secondary | Neuroinflammatory Biomarker Concentration | On day 1 (visit 1) and day 28 (visit 2) of the 28 day study. | Blood analysis for circulating concentration of neuroinflammatory protein, Interluken-6 |
| Secondary | EEG-fNRIS | On day 1 (visit 1) and day 28 (visit 2) of the 28 day study. | Combined EEG-fNIRS brain scan to identify regional brain activation. Specifically a resting state EEG-fNIRS will be utilized to compare the timecourse of frontal theta-, beta-, and alpha-wave peak frequency and absolute power versus BOLD signal (oxygenated hemogloben) in the frontal region. Synchronized EEG and fNIRS scans will aid in confirming type and degree of alterations in subcortical brain activity. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as |
|---|---|
| Stroop Color-Word Test | Secondary outcome |
Source ConductCognition
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07642739
GET https://conductscience.org/api/trials/v1/NCT07642739/registered